EUVIMEDEUVIMED entdecken
Crossref

Dysregulated Apoptosis and Autophagy in Childhood Epilepsy: Correlation to Clinical and Pharmacological Patterns

Ahmed El-Abd Ahmed, Mohammed H Hassan iD, Asmaa A Abdelfatah, Ali Helmi Bakri

Neuropediatrics · 01.10.2024 · 55 (05) · 327-336

DOI: 10.1055/s-0044-1788032 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuropediatrics, erschienen am 01.10.2024. Verfasst von Ahmed El-Abd Ahmed und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Faculty of Medicine, South Valley University, Qena, Egypt. Hauptthemen laut MEDLINE: Epilepsy, Apoptosis, Caspase 3, Autophagy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

We aimed to assess the serum levels of caspase-3 as a marker of apoptosis and microtubule-associated protein 1A/1B-light chain 3 (MAP1-LC3) as an autophagy marker in epileptic children with various clinical and pharmacological types.

Methods

This case–control study was carried out on 90 participants (50 pediatric patients with epilepsy and 40 healthy matched children), the patients were categorized into three groups: Group (A): 25 pharmacosensitive epilepsy, Group (B): 25 pharmacoresistant epilepsy, and Group (C): 40 (age, sex, and body mass index) matched healthy children selected as controls. Serum caspase-3 and MAP1-LC3 were measured in all study groups, using commercially available ELISA kits.

Results

Serum caspase-3 was significantly higher among epileptic children, especially in the pharmacoresistant group, cases managed with multiple antiepileptic drugs, and cases with abnormal EEG findings. Conversely, circulating MAP1-LC3 levels showed a significant reduction in epilepsy cases, particularly in pharmacoresistant cases, in cases treated with multiple antiepileptic drugs, and in cases with abnormal EEG data. A significant negative correlation between serum caspase-3 and MAP1-LC3 was found among epileptic children (r = −0.369, p = 0.0083). Serum caspase-3 was a more valid biomarker in helping diagnose childhood epilepsy, while serum MAP1-LC3 was more valid in predicting pharmacoresistant type.

Conclusion

The study reveals that serum caspase-3 levels were significantly elevated, particularly in pharmacoresistant cases and those managed with multiple drugs. Conversely, MAP1-LC3 levels were significantly reduced in epilepsy cases, suggesting potential involvement of altered apoptosis and autophagy in childhood epilepsy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EpilepsyApoptosisCaspase 3AutophagyAnticonvulsantsMicrotubule-Associated ProteinsHumansMaleChildFemaleCase-Control StudiesChild, PreschoolDrug Resistant EpilepsyAdolescentBiomarkersElectroencephalography

Substanzen

Caspase 3AnticonvulsantsMicrotubule-Associated ProteinsCASP3 protein, humanMAP1LC3A protein, humanBiomarkers

Autor:innen und Institutionen

  • Department of Pediatrics, Faculty of Medicine, South Valley University, Qena, Egypt.
  • Department of Medical Biochemistry, Faculty of Medicine, South Valley University, Qena, Egypt.

ORCID-Profile: Mohammed H Hassan

Zitieren

APA

Ahmed, A. E., Hassan, M. H., Abdelfatah, A. A., & Bakri, A. H. (2024). Dysregulated Apoptosis and Autophagy in Childhood Epilepsy: Correlation to Clinical and Pharmacological Patterns. Neuropediatrics, 55(05), 327-336. https://doi.org/10.1055/s-0044-1788032

Vancouver

Ahmed AE, Hassan MH, Abdelfatah AA, Bakri AH. Dysregulated Apoptosis and Autophagy in Childhood Epilepsy: Correlation to Clinical and Pharmacological Patterns. Neuropediatrics. 2024;55(05):327-336. doi:10.1055/s-0044-1788032

BibTeX
@article{Ahmed2024,
  author = {Ahmed, Ahmed El-Abd and Hassan, Mohammed H and Abdelfatah, Asmaa A and Bakri, Ali Helmi},
  title = {Dysregulated Apoptosis and Autophagy in Childhood Epilepsy: Correlation to Clinical and Pharmacological Patterns},
  journal = {Neuropediatrics},
  year = {2024},
  volume = {55},
  number = {05},
  pages = {327--336},
  doi = {10.1055/s-0044-1788032}
}
Kostenlos starten →